NO20053959D0 - Medikament omfattende hoy-aktiv langtidsvarende beta-2-abonist i kombinasjon med andre aktive bestanddeler - Google Patents

Medikament omfattende hoy-aktiv langtidsvarende beta-2-abonist i kombinasjon med andre aktive bestanddeler

Info

Publication number
NO20053959D0
NO20053959D0 NO20053959A NO20053959A NO20053959D0 NO 20053959 D0 NO20053959 D0 NO 20053959D0 NO 20053959 A NO20053959 A NO 20053959A NO 20053959 A NO20053959 A NO 20053959A NO 20053959 D0 NO20053959 D0 NO 20053959D0
Authority
NO
Norway
Prior art keywords
active
medication
subscriber
combination
long
Prior art date
Application number
NO20053959A
Other languages
English (en)
Other versions
NO20053959L (no
Inventor
Roberta Razzetti
Fiorella Pastore
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32748803&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053959(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20053959D0 publication Critical patent/NO20053959D0/no
Publication of NO20053959L publication Critical patent/NO20053959L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20053959A 2003-02-27 2005-08-25 Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler NO20053959L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03004184A EP1452179A1 (en) 2003-02-27 2003-02-27 Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
PCT/EP2004/001960 WO2004075896A1 (en) 2003-02-27 2004-02-27 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients

Publications (2)

Publication Number Publication Date
NO20053959D0 true NO20053959D0 (no) 2005-08-25
NO20053959L NO20053959L (no) 2005-11-28

Family

ID=32748803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053959A NO20053959L (no) 2003-02-27 2005-08-25 Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler

Country Status (32)

Country Link
US (1) US20070020190A1 (no)
EP (3) EP1452179A1 (no)
JP (1) JP2006519204A (no)
KR (1) KR20050104367A (no)
CN (2) CN100370986C (no)
AR (1) AR043419A1 (no)
AT (1) ATE401887T1 (no)
AU (1) AU2004216472B2 (no)
BR (1) BRPI0408047A (no)
CA (1) CA2517321A1 (no)
CY (1) CY1108360T1 (no)
DE (1) DE602004015260D1 (no)
DK (1) DK1603565T3 (no)
EA (1) EA008828B1 (no)
ES (1) ES2309503T3 (no)
HK (1) HK1087009A1 (no)
HR (1) HRP20050726A2 (no)
MA (1) MA27630A1 (no)
ME (1) MEP32208A (no)
MX (1) MXPA05009007A (no)
NO (1) NO20053959L (no)
NZ (1) NZ541997A (no)
PE (1) PE20050290A1 (no)
PL (1) PL377814A1 (no)
PT (1) PT1603565E (no)
RS (1) RS20050615A (no)
SA (1) SA04250122B1 (no)
SI (1) SI1603565T1 (no)
TN (1) TNSN05186A1 (no)
UA (1) UA82217C2 (no)
WO (1) WO2004075896A1 (no)
ZA (1) ZA200506820B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
EP1651224B1 (en) * 2003-07-31 2011-10-05 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising an anticholinergic and a betamimetic
JP2007501194A (ja) * 2003-08-05 2007-01-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドとβ模倣薬を含む吸入用薬剤
PL1670482T5 (pl) * 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
MX2007011273A (es) * 2005-03-16 2007-11-08 Meda Pharma Gmbh & Co Kg La combinacion de anticolinergicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias.
WO2006105401A2 (en) * 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
EP1915129B1 (en) * 2005-08-01 2009-10-28 CHIESI FARMACEUTICI S.p.A. Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
ATE529399T1 (de) * 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
PL2098248T3 (pl) * 2005-12-21 2012-11-30 Meda Pharma Gmbh & Co Kg Kombinacja antycholinergików, glukokortykoidów i beta2-agonistów do leczenia chorób zapalnych
EP2029127A1 (en) * 2006-05-24 2009-03-04 Boehringer Ingelheim International GmbH New long-acting drug combinations for the treatment of respiratory diseases
EP1953143A1 (en) * 2007-01-30 2008-08-06 CHIESI FARMACEUTICI S.p.A. Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
EP2327403A3 (en) * 2007-02-19 2011-08-31 Cipla Limited Pharmaceutical combinations of at least two bronchodilators
EP2230934B8 (en) 2007-12-14 2012-10-24 AeroDesigns, Inc Delivering aerosolizable food products
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2309858A4 (en) * 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
WO2010097188A1 (en) * 2009-02-25 2010-09-02 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a salt of carmoterol and a corticosteroid
AU2010252354B2 (en) * 2009-05-25 2016-05-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid
DK2435024T3 (en) 2009-05-29 2016-10-24 Pearl Therapeutics Inc Compositions for the respiratory delivery of active agents and related methods and systems
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
WO2011136753A1 (en) * 2010-04-26 2011-11-03 Mahmut Bilgic Combination of carmoterol and fluticasone for use in the treatment respiratory diseases
CN102247597B (zh) * 2010-05-19 2015-01-07 天津金耀集团有限公司 一种糖皮质激素与支气管扩张剂的吸入剂
CN110237260A (zh) * 2010-07-16 2019-09-17 希普拉有限公司 包含r(+)布地奈德和一种或多种支气管扩张剂的药物组合物
WO2012010854A1 (en) 2010-07-23 2012-01-26 Cipla Limited Inhalation formulations comprising carmoterol in combination with a corticosteroid
CN102416179B (zh) * 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
HUE038899T2 (hu) * 2013-03-15 2018-12-28 Verona Pharma Plc Gyógyszer kombináció
US10117891B2 (en) 2014-09-16 2018-11-06 India Globalization Capital, Inc. Cannabinoid composition for treating pain
EP3223807B1 (en) 2014-11-24 2021-09-15 The Board of Trustees of the University of Illinois Method of preventing or treating a pulmonary disease or condition
US10751300B2 (en) 2015-01-25 2020-08-25 India Globalization Capital, Inc. Composition and method for treating seizure disorders
WO2017027651A1 (en) * 2015-08-12 2017-02-16 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
CA3027862A1 (en) 2016-06-15 2017-12-21 India Globalization Capital, Inc. Method and composition for treating seizure disorders
CN115337311B (zh) * 2022-09-26 2023-05-09 南京恒道医药科技股份有限公司 一种治疗呼吸系统疾病的组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP0969816B1 (en) * 1997-03-20 2004-12-15 Schering Corporation Preparation of powder agglomerates
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US20020081266A1 (en) * 1999-08-20 2002-06-27 Norton Healthcare Ltd. Spray dried powders for pulmonary or nasal administration
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
DZ3358A1 (fr) * 2000-05-22 2001-11-29 Chiesi Farma Spa Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
HUE044926T2 (hu) * 2002-03-01 2019-11-28 Chiesi Farm Spa Szuperfinom formoterolkészítmény
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
CN100370986C (zh) 2008-02-27
EP1834643A3 (en) 2007-10-24
BRPI0408047A (pt) 2006-02-14
MXPA05009007A (es) 2005-10-18
CN1753678A (zh) 2006-03-29
SA04250122B1 (ar) 2009-03-11
HRP20050726A2 (en) 2006-02-28
PE20050290A1 (es) 2005-05-26
SI1603565T1 (sl) 2008-10-31
HK1087009A1 (en) 2006-10-06
ZA200506820B (en) 2006-11-29
US20070020190A1 (en) 2007-01-25
AU2004216472A1 (en) 2004-09-10
PT1603565E (pt) 2008-10-06
EP1834643A2 (en) 2007-09-19
EA008828B1 (ru) 2007-08-31
PL377814A1 (pl) 2006-02-20
DK1603565T3 (da) 2008-11-10
AU2004216472B2 (en) 2009-08-06
NZ541997A (en) 2008-12-24
ES2309503T3 (es) 2008-12-16
ATE401887T1 (de) 2008-08-15
EP1452179A1 (en) 2004-09-01
WO2004075896A1 (en) 2004-09-10
NO20053959L (no) 2005-11-28
UA82217C2 (uk) 2008-03-25
JP2006519204A (ja) 2006-08-24
MA27630A1 (fr) 2005-11-01
CN101244063A (zh) 2008-08-20
DE602004015260D1 (de) 2008-09-04
EA200501108A1 (ru) 2006-04-28
CA2517321A1 (en) 2004-09-10
EP1603565B1 (en) 2008-07-23
KR20050104367A (ko) 2005-11-02
EP1603565A1 (en) 2005-12-14
MEP32208A (en) 2010-10-10
CY1108360T1 (el) 2014-02-12
RS20050615A (en) 2007-09-21
AR043419A1 (es) 2005-07-27
TNSN05186A1 (en) 2007-06-11

Similar Documents

Publication Publication Date Title
NO20053959D0 (no) Medikament omfattende hoy-aktiv langtidsvarende beta-2-abonist i kombinasjon med andre aktive bestanddeler
ZA200600099B (en) Active agents combination exhibiting insecticidal and acaricide properties
ATE300325T1 (de) Nadelloser injektor in miniaturausführung
EP1689348A4 (en) OLIGOSACCHARIDE COMPOSITIONS AND ITS USE IN THE TREATMENT OF INFECTIONS
DK1721623T3 (da) Absorberende polymersammensætninger, medicinske artikler og fremgangsmåder
ATE374016T1 (de) Tablette mit hohem wirkstoffgehalt
IL175074A0 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatement, modification and management of pain
TW200716628A (en) Novel compounds
CR7921A (es) Formulaciones farmaceuticas liquidas de palonosetron
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
FR2866884B1 (fr) Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
ZA200600098B (en) Active agents combination exhibiting insecticidal and acaricide properties
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
NO20051261L (no) Morfin-6-glukuronidsalt
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
ATE417048T1 (de) N-ä3-(3-substituierte pyrazoloä1,5-aüpyrimidin-7- yl)phenylü-sulfonamide, und zusammensetzungen, und damit in zusammenhang stehende verfahren
WO2005034857A8 (en) Methods and compositions comprising diamines as new anti-tubercular therapeutics
ITMI20030972A1 (it) Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
DE60323138D1 (de) Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
NL1027109A1 (nl) Verbinding en gebruik bij behandeling.
FR2866886B1 (fr) Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique
EP1591123A4 (en) USE OF NARINGENINE, NARINGIN AND THEIR SALTS AS EXPERTS IN THE TREATMENT OF COUGH AND COMPOSITIONS THEREOF

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application